CMS' final drug price rule doesn't include price concessions

Modern Healthcare: The Trump administration on Thursday released a final rule aimed at boosting transparency of drug costs on Medicare Part D, but it does not include a proposal to pass on price concessions negotiated by the pharmacy to patients.

While the agency had wanted to implement the new policy in 2020, the CMS said in a release that it is not implementing it after receiving more than 4,000 comments.

Read article